Key facts
- It has raised $980K; the latest was Later Stage VC in Jun 2025.
- Notable investors include European Innovation Council, Eurostars, Great Stuff Ventures, Revere Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Augmedit
- ·The full record, as it builds
Funding rounds
No funding rounds for Augmedit are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Augmedit
Developer of medical augmented reality software intended to turn two-dimensional imaging into a three-dimensional holographic use. The company offers tools through which surgeons can create their patient holograms with a few mouse clicks, to solve neuronavigation issues, enabling the medical field employees to work with holograms to prepare individualized treatment plans.
- Sector
- Healthcare
- HQ
- Naarden, Netherlands
- Founded
- 2018
- Employees
- 10
- Website
- augmedit.com/
- Ownership
- Privately Held (backing)
Augmedit doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Augmedit shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Augmedit in its N-PORT filings yet. We sweep new filings monthly.